The inflammatory reaction pattern distinguishes primary dysferlinopathies from idiopathic inflammatory myopathies: An important role for the membrane attack complex

Acta Neuropathologica

Volumn 112, Issue 3, 2006, Pages 325-332

  Brunn, Anna ^a   Schröder, Rolf ^a   Deckert, Martina ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Cytokines; Inflammation; Membrane attack complex; Primary dysferlinopathy; T cells

Indexed keywords

CD20 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD68 ANTIGEN; CD8 ANTIGEN; COMPLEMENT MEMBRANE ATTACK COMPLEX; CYTOKINE; DYSFERLIN; GAMMA INTERFERON; GRANZYME B; HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MONOCLONAL ANTIBODY; MYOSIN; PERFORIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CASE REPORT; CELL COMPOSITION; CELL INFILTRATION; CLINICAL EXAMINATION; CONTROLLED STUDY; DERMATOMYOSITIS; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; HUMAN; HUMAN CELL; HUMAN TISSUE; INCLUSION BODY MYOSITIS; INFLAMMATION; MACROPHAGE; MUSCLE BIOPSY; MUSCLE CELL; MYOPATHY; POLYMYOSITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; T LYMPHOCYTE; UPREGULATION; WESTERN BLOTTING;

ANTIGENS, CD8; BLOTTING, WESTERN; COMPLEMENT MEMBRANE ATTACK COMPLEX; CYTOKINES; DIAGNOSIS, DIFFERENTIAL; FLUORESCENT ANTIBODY TECHNIQUE; GENES, MHC CLASS I; GRANZYMES; HUMANS; INFLAMMATION; INTERFERON TYPE II; INTERFERON-GAMMA; MACROPHAGES; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MUSCLE PROTEINS; MUSCULAR DISEASES; MYOSITIS, INCLUSION BODY; PERFORIN; PORE FORMING CYTOTOXIC PROTEINS; T-LYMPHOCYTES;

EID: 33747756470     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00401-006-0113-5     Document Type: Article

References (33)

1. Anderson LV, Davison K, Moss JA, Young C, Cullen MJ, Walsh J, Johnson MA, Bashir R, Britton S, Keers S, Argov Z, Mahjneh I, Fougerousse F, Beckmann JS, Bushby KM (1999) Dysferlin is a plasma membrane protein and is expressed early in human development. Hum Mol Genet 8:855-861
2. Arahata K, Engel AG (1986) Monoclonal antibody analysis of mononuclear cells in myopathies. III: Immunoelectron microscopy aspects of cell-mediated muscle fiber injury. Ann Neurol 19:112-125
3. Argov Z, Sadeh M, Mazor K, Soffer D, Kahana E, Eisenberg I, Mitrani-Rosenbaum S, Richard I, Beckmann J, Keers S, Bashir R, Bushby K, Rosenmann H (2000) Muscular dystrophy due to dysferlin deficiency in Libyan Jews. Clinical and genetic features. Brain 123:1229-1237
4. Austin SG, Pappolla MA, Dimachkie M, Vriesendorp FJ (1995) A confusing case of Miyoshi distal myopathy. Muscle Nerve 18:922-923
5. Bansal D, Miyake K, Vogel SS, Groh S, Chen CC, Williamson R, McNeil PL, Campbell KP (2003) Defective membrane repair in dysferlin-deficient muscular dystrophy. Nature 423:168-172
6. Cherin P, Herson S, Crevon MC, Hauw JJ, Cervera P, Galanaud P, Emilie D (1996) Mechanisms of lysis by activated cytotoxic cells expressing perforin and granzyme-B genes and the protein TIA-1 in muscle biopsies of myositis. J Rheumatol 23:1135-1142
7. Confalonieri P, Oliva L, Andreetta F, Lorenzoni R, Dassi P, Mariani E, Morandi L, Mora M, Cornelio F, Mantegazza R (2003) Muscle inflammation and MHC class I up-regulation in muscular dystrophy with lack of dysferlin: An immunopathological study. J Neuroimmunol 142:130-136
8. Dalakas MC (1991) Polymyositis, dermatomyositis and inclusion-body myositis. N Engl J Med 325:1487-1498
9. Dalakas MC (2002a) Muscle biopsy findings in inflammatory myopathies. Rheum Dis Clin North Am 28:779-798
10. Dalakas MC (2002b) Understanding the immunopathogenesis of inclusion-body myositis: Present and future prospects. Rev Neurol (Paris) 158:948-958
11. Fanin M, Angelini C (2002) Muscle pathology in dysferlin deficiency. Neuropathol Appl Neurobiol 28:461-470
12. Gallardo E, Rojas-Garcia R, de Luna N, Pou A, Brown RH, Jr, Illa I (2001) Inflammation in dysferlin myopathy: Immunohistochemical characterization of 13 patients. Neurology 57:2136-2138
13. Goebels N, Michaelis D, Engelhardt M, Huber S, Bender A, Pongratz D, Johnson MA, Wekerle H, Tschopp J, Jenne D, Hohlfeld R (1996) Differential expression of perforin in muscle-infiltrating T cells in polymyositis and dermatomyositis. J Clin Invest 97:2905-2910
14. Hohlfeld R, Engel AG (1994) The immunobiology of muscle. Immunol Today 15:269-274
15. Illarioshkin SN, Ivanova-Smolenskaya IA, Greenberg CR, Nylen E, Sukhorukov VS, Poleshchuk VV, Markova ED, Wrogemann K (2000) Identical dysferlin mutation in limb-girdle muscular dystrophy type 2B and distal myopathy. Neurology 55:1931-1933
16. Kuru S, Inukai A, Kato T, Liang Y, Kimura S, Sobue G (2003) Expression of tumor necrosis factor-alpha in regenerating muscle fibers in inflammatory and non-inflammatory myopathies. Acta Neuropathol (Berl) 105:217-224
17. Langermans JA, Van der Hulst ME, Nibbering PH, Hiemstra PS, Fransen L, Van Furth R (1992) IFN-gamma-induced L-arginine-dependent toxoplasmastatic activity in murine peritoneal macrophages is mediated by endogenous tumor necrosis factor-alpha. J Immunol 148:568-574
18. Lennon NJ, Kho A, Bacskai BJ, Perlmutter SL, Hyman BT, Brown RH, Jr (2003) Dysferlin interacts with annexins A1 and A2 and mediates sarcolemmal wound-healing. J Biol Chem 278:50466-50473
19. Lepidi H, Frances V, Figarella-Branger D, Bartoli C, Machado-Baeta A, Pellissier JF (1998) Local expression of cytokines in idiopathic inflammatory myopathies. Neuropathol Appl Neurobiol 24:73-79
20. Lieberman J (2003) The ABCs of granule-mediated cytotoxicity: New weapons in the arsenal. Nat Rev Immunol 3:361-370
21. Liu J, Aoki M, Illa I, Wu C, Fardeau M, Angelini C, Serrano C, Urtizberea JA, Hentati F, Hamida MB, Bohlega S, Culper EJ, Amato AA, Bossie K, Oeltjen J, Bejaoui K, McKenna-Yasek D, Hosler BA, Schurr E, Arahata K, de Jong PJ, Brown RH, Jr. (1998) Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy. Nat Genet 20:31-36
22. Liu J, Miwa T, Hilliard B, Chen Y, Lambris JD, Wells AD, Song WC (2005) The complement inhibitory protein DAF (CD55) suppresses T cell immunity in vivo. J Exp Med 201:567-577
23. Lundberg I, Ulfgren AK, Nyberg P, Andersson U, Klareskog L (1997) Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies. Arthritis Rheum 40:865-874
24. Mastaglia FL, Phillips BA (2002) Idiopathic inflammatory myopathies: epidemiology, classification, and diagnostic criteria. Rheum Dis Clin North Am 28:723-741
25. Matsuda C, Aoki M, Hayashi YK, Ho MF, Arahata K, Brown RH, Jr (1999) Dysferlin is a surface membrane-associated protein that is absent in Miyoshi myopathy. Neurology 53:1119-1122
26. McNally EM, Ly CT, Rosenmann H, Mitrani Rosenbaum S, Jiang W, Anderson LV, Soffer D, Argov Z (2000) Splicing mutation in dysferlin produces limb-girdle muscular dystrophy with inflammation. Am J Med Genet 91:305-312
27. Nakagawa M, Matsuzaki T, Suehara M, Kanzato N, Takashima H, Higuchi I, Matsumura T, Goto K, Arahata K, Osame M (2001) Phenotypic variation in a large Japanese family with Miyoshi myopathy with nonsense mutation in exon 19 of dysferlin gene. J Neurol Sci 184:15-19
28. Rowin J, Meriggioli MN, Cochran EJ, Sanders DB (1999) Prominent inflammatory changes on muscle biopsy in patients with Miyoshi myopathy. Neuromuscul Disord 9:417-420
29. Selcen D, Stilling G, Engel AG (2001) The earliest pathologic alterations in dysferlinopathy. Neurology 56:1472-1481
30. Spuler S, Engel AG (1998) Unexpected sarcolemmal complement membrane attack complex deposits on nonnecrotic muscle fibers in muscular dystrophies. Neurology 50:41-46
31. Tews DS, Goebel HH (1996) Cytokine expression profile in idiopathic inflammatory myopathies. J Neuropathol Exp Neurol 55:342-347
32. Weiler T, Bashir R, Anderson LV, Davison K, Moss JA, Britton S, Nylen E, Keers S, Vafiadaki E, Greenberg CR, Bushby CR, Wrogemann K (1999) Identical mutation in patients with limb girdle muscular dystrophy type 2B or Miyoshi myopathy suggests a role for modifier gene(s). Hum Mol Genet 8:871-877
33. Wenzel K, Zabojszcza J, Carl M, Taubert S, Lass A, Harris CL, Ho M, Schulz H, Hummel O, Hubner N, Osterziel KJ, Spuler S (2005) Increased susceptibility to complement attack due to down-regulation of decay-accelerating factor/CD55 in dysferlin-deficient muscular dystrophy. J Immunol 175:6219-6225